Saturday, January 15, 2011

Tasmanian Honey Producers Seek to Tap Medicinal Honey Market

Beyond Toast and Tea
By Eliza Wood, ABC, 1/13/2011

Tasmanian honey producers are hoping to tap the overseas medicinal honey market with the formation of an 'active honey' group.

Science continues to back up the argument that honey can be used for more things than just toast and tea.

The Tasmanian Active Honey Group initially includes six businesses, and they'll have to adhere to certain standards if they're to market under the organisation.

Manuka or tea tree honey has antibacterial qualities, and it's also been found recently that leatherwood is one of the highest antioxidant honeys in the world.

Nicola Charles from Blue Hills Honey at Mawbanna in the state's north west says these honeys have long been sold for food, but not often for medicine.

"[In south east Asian markets] they actually look at honey as a medicinal product, they don't see it as a food…

Friday, January 14, 2011

Honey May be Used as a Sugar Substitute by Diabetes Patients

The Glycemic and Peak Incremental Indices of Honey, Sucrose and Glucose in Patients with Type 1 Diabetes Mellitus: Effects on C-peptide Level—A Pilot Study Acta Diabetologica, Online First

Our study was a case–control cross-sectional study that was conducted on 20 children and adolescents suffering from type 1 diabetes mellitus and ten healthy non-diabetic children and adolescents serving as controls.

The mean age of patients was 10.95 years. Oral sugar tolerance tests using glucose, sucrose and honey and measurement of fasting and postprandial serum C-peptide levels were done for all subjects in three separate sittings. The glycemic index (GI) and the peak incremental index (PII) were then calculated for each subject.

Honey, compared to sucrose, had lower GI and PII in both patients (P < 0.001) and control (P < 0.05) groups. In the patients group, the increase in the level of C-peptide after using honey was not significant when compared with using either glucose or sucrose. However, in the control group, honey produced a significant higher C-peptide level, when compared with either glucose or sucrose.

In conclusion, honey, because of its lower GI and PII when compared with sucrose, may be used as a sugar substitute in patients with type 1 diabetes mellitus.

Thursday, January 13, 2011

Video: Honey Inspired Bandage Heals 'More Quickly'

BBC, 1/7/2011

He was part of the team which invented the pregnancy test but now Professor Paul Davis has designed a new bandage based in part on the chemistry of honey.

Professor Davis claims it heals wounds more quickly than standard dressings.

Graham Satchell reports.

Wednesday, January 12, 2011

Pollen-Honey Mixture Helps Control Allergy Symptoms

Birch Pollen Honey for Birch Pollen Allergy - A Randomized Controlled Pilot Study
Int Arch Allergy Immunol, 2010 Dec 23;155(2):160-166

Background: Only a few randomized controlled trials have been carried out to evaluate various complementary treatments for allergic disorders. This study assessed the effects of the preseasonal use of birch pollen honey (BPH; birch pollen added to honey) or regular honey (RH) on symptoms and medication during birch pollen season.

Methods: Forty-four patients (59% female, mean age 33 years) with physician-diagnosed birch pollen allergy consumed either BPH or RH daily in incremental amounts from November 2008 to March 2009. Seventeen patients (53% female, mean age 36 years) on their usual allergy medication served as the control group. From April to May, patients recorded daily rhinoconjunctival and other symptoms and their use of medication. Fifty patients completed the study.

Results: During birch pollen season in 2009, BPH patients reported a 60% lower total symptom score (p < 0.01), twice as many asymptomatic days (p < 0.01), and 70% fewer days with severe symptoms (p < 0.001), and they used 50% less antihistamines (p < 0.001) compared to the control group. The differences between the BPH and RH groups were not significant. However, the BPH patients used less antihistamines than did the RH patients (p < 0.05).

Conclusions: Patients who preseasonally used BPH had significantly better control of their symptoms than did those on conventional medication only, and they had marginally better control compared to those on RH. The results should be regarded as preliminary, but they indicate that BPH could serve as a complementary therapy for birch pollen allergy.

Tuesday, January 11, 2011

Malaysian Tualang Honey Could Help Treat Symptoms of Menopause

The Effects of Tualang Honey on Female Reproductive Organs, Tibia Bone and Hormonal Profile in Ovariectomised Rats - Animal Model for Menopause
BMC Complementary and Alternative Medicine, 31 December 2010

Background: Honey is a highly nutritional natural product that has been widely used in folk medicine for a number of therapeutic purposes. We evaluated whether Malaysian Tualang honey (AgroMas, Malaysia) was effective in reducing menopausal syndrome in ovariectomised female rats; an animal model for menopause.

Methods: The rats were divided into two control groups and three test groups. The control groups were sham-operated (SH) and ovariectomised (OVX) rats. The SH and OVX control rats were fed on 0.5 ml of distill water. The rats in the test groups were fed with low dose 0.2 g/kg (THL), medium dose, 1.0 g/kg (THM) and high dose 2.0 g/kg (THH) of Tualang honey in 0.5 ml of distill water. The administration was given by oral gavage once daily for 2 weeks. The reproductive organs (uterus and vagina), tibia bone and aorta were taken for histopathological examination while serum for hormonal assays.

Results: Administration of Tualang honey for 2 weeks to ovariectomised rats significantly increased the weight of the uterus and the thickness of vaginal epithelium, restore the tibia bones and reduced the body weight compared to rats in the ovariectomised group. The levels of estradiol and progesterone, in honey treated groups were markedly lower than that in the OVX group. At low doses (0.2 g/kg; THL group) of Tualang honey there was an increased in serum free testosterone levels compared to OVX group (P<0.01). Progesterone concentrations was significantly decreased in the OVX group as compared to SHAM group (P<0.05).

Conclusions: Tualang honey was shown to have beneficial effects on menopausal (ovariectomised) rats by preventing uterine atrophy, increased bone density and suppression of increased body weight. Honey could be an alternative to HRT.

Monday, January 10, 2011

Manuka Honeys May Reduce Oral Pathogens Within Dental Plaque

The in vitro Effect of Manuka Honeys on Growth and Adherence of Oral Bacteria
Anaerobe, Article in Press

Honey has been used since ancient times and more recently, for the healing of wounds and against infectious diseases.The aim of our study was to investigate the effect of two manuka honeys showing different potencies of their antibacterial activity, on potentially pathogenic oral bacteria.

The antimicrobial activity was examined by determining the MIC and MBC using the macro dilution broth technique. The effect on the adherence was tested on growing cells of Streptococcus mutans on a glass surface and on a multi-species biofilm grown on saliva-coated hydroxyapatite discs.

As expected, the antibacterial activity of manuka (with higher potency of antibacterial activity) was the most important. The two tested honeys weakly inhibited the adherence of S.mutans cells to a glass surface at sub-MIC concentration.

Manuka showed a total inhibition of multi species biofilm at the concentration of 200 μg/ml. manuka inhibited biofilm formation weakly at the concentration of 200 μg/ml but firmly at the concentration of 500 μg/ml.

Our findings suggest that manuka honeys might be able to reduce oral pathogens within dental plaque. These two honeys appear to be able to control dental biofilm deposit.

Sunday, January 09, 2011

Medicinal Honey Used to Treat MSRA-Infected Titanium Mesh

Salvage of an Infected Titanium Mesh in a Large Incisional Ventral Hernia Using Medicinal Honey and Vacuum-Assisted Closure: A Case Report and Literature Review
Hernia, Online First

The overall reported percentage of mesh infections is 1.3%. Infections after incisional ventral hernia repair depend on many factors. Salvaging an infected mesh should be the priority, because serious complications are reported following mesh removal.

In this case report, a methicillin-resistant Staphylococcus aureus (MRSA)-infected titanium mesh was salvaged by a novel technique, not requiring removal.

The combination of vacuum-assisted closure (VAC™ therapy) of the wound and medical honey (L-Mesitran™) proved to be successful in leaving the mesh in situ. We report the successful management of this infected titanium mesh and review the literature regarding the possible pathogenetic mechanisms and treatment options.

Saturday, January 08, 2011

Ethiopian Honey Effective Against Oral Fungus in AIDS Patients

Effect of Ethiopian Multiflora Honey on Fluconazole-Resistant Candida Species Isolated from the Oral Cavity of AIDS Patients
International Journal of STD & AIDS, Volume 21, Number 11, Pp. 741-745

This study aimed to determine the antifungal effect of Ethiopian multiflora honey against Candida species isolated from the oral cavity of AIDS patients.

Oral rinses were obtained from 13 AIDS patients and cultured on CHROMagar plates at 37°C for 48 hours. Candida species were identified by microbiological and molecular techniques. The antifungal effect of the honey sample on Candida was investigated by an agar dilution technique. Susceptibility of the Candida species to fluconazole was tested following a semi-modified microdilution method.

Growth of both fluconazole-susceptible and -resistant Candida species was inhibited with a minimum fungicidal concentration (MFC) of 35–40% (v/v) honey. The MFC of different Candida species was not significantly different (P > 0.05). From the total of 25 Candida isolates tested for susceptibility, 11 (44%), eight (32%) and six (24%) of the isolates were sensitive (minimum inhibitory concentrations [MICs] < 8 µg/mL), susceptible (dose-dependent: MICs 16–32 µg/mL) and resistant (MICs > 64 µg/mL) to fluconazole, respectively.

Ethiopian multiflora honey has antifungal activity against fluconazole-resistant Candida species isolated from the oral cavity of AIDS patients. This supports the existing folkloric practice of using honey to treat oral lesions. Nevertheless, identification of the bioactive agents in honey, their clinical evaluation and pharmacological standardization are crucial.

Friday, January 07, 2011

Propolis Component May Help Treat Breast Cancer

Cytotoxic Activity of Nemorosone in Human MCF-7 Breast Cancer Cells
Can J Physiol Pharmacol, 2011 Jan;89(1):50-7

Estrogen receptor (ER) antagonists have been widely used for breast cancer treatment; however, patients have increasingly shown resistance and sensitivity to the high toxicity of these drugs, and identification of novel targeted therapies is therefore required.

To determine whether nemorosone, a polycyclic polyisoprenylated benzophenone isolated from floral resins of Clusia rosea Jacq. and Cuban propolis samples, exerts anticancer effects on human breast cancer cells, estrogen receptor positive (ERα+) MCF-7 and estrogen receptor negative (ERα-) MDA-MB-231 and LNCaP cells were used.

Cells were treated with nemorosone alone or in association with 17β-estradiol (E2) or an ER antagonist, ICI 182,780, a selective ER downregulator that completely abrogates estrogen-sensitive gene transcription. Nemorosone inhibited the cell viability of ERα+ but not of ERα- cells. In MCF-7, nemorosone induced inhibition of cell growth by blocking the cell cycle in the G0/G1 phase.

Moreover, the expression of pERK1/2 and pAkt, considered to be hallmarks of the nongenomic estrogen signalling pathway, were reduced in MCF-7 cells treated with nemorosone. All these effects were enhanced by ICI 182,780. However, nemorosone was not able to interfere with E2-induced Ca2+ release.

These findings suggest that nemorosone may have therapeutic application in the treatment of breast cancer because of its activity on ERα.

Les antagonistes des récepteurs des œstrogènes sont largement utilisés pour le traitement du cancer du sein; toutefois, les patients montrent de plus en plus de résistance à ces médicaments et de sensibilité leur toxicité, d’où la nécessité de mettre au point de nouvelles thérapies ciblées. Pour déterminer si le némorosone, un benzophénone polyisoprénylé polycyclique isolé des résines des fleurs de Clusia rosea et d’échantillons de propolis de Cuba, a un effet anticancéreux sur les cellules de cancer du sein, on a utilisé les cellules MCF-7 positives aux récepteurs des œstrogènes (REα+) et les cellules MDA-MB-231 et LNCaP négatives à ces récepteurs (REα–). On a traité les cellules avec le némorosone seul ou en association avec le 17β-estradiol (E2) ou l’antagoniste des RE, ICI 182,780, un régulateur négatif sélectif de RE qui supprime totalement la transcription des gènes sensibles aux œstrogènes. Le némorosone a inhibé la viabilité des cellules des REα+, mais pas des celles REα–. Dans les cellules MCF-7, le némorosone a inhibé la croissance cellulaires en bloquant le cycle des cellules dans la phase G0/G1. De plus, l’expression de pERK1/2 et de pAkt, considérée comme caractéristique dans la voie de signalisation des œstrogènes non génomiques, a été diminuée dans les cellules MCF-7 traitées avec le némorosone. Tous ces effets ont été stimulés par ICI 182,780. Toutefois, le némorosone n’a pu interférer avec la libération de Ca2+ induite par E2. Ces résultats donnent à penser que le némorosone pourrait avoir une application thérapeutique dans le traitement du cancer du sein en raison de son activité sur les REα.

Thursday, January 06, 2011

Recommendation for Standardization of Bee Pollen Analysis

Evaluation of the Botanical Origin of Commercial Dry Bee Pollen Load Batches Using Pollen Analysis: A Proposal for Technical Standardization
An Acad Bras Cienc, 2010 Dec;82(4):893-902.

High quality of bee pollen for commercial purpose is required. In order to attend the consumer with the best identification of the botanical and floral origin of the product, 25 bee pollen batches were investigated using two techniques of pollen grain preparation.

The first started to identify pollen loads of different colors in two grams of each well mixed batch, and the second to identify pollen grains in a pool made of all the pollen loads comprised in two grams.

The best result was obtained by this last technique, when a pollen grain suspension was dropped on a microscope slide and circa 500 pollen grains were counted per sample. This analysis resulted in the recognition of monofloral and bifloral pollen batches, while the use of the first technique resulted in all samples receiving a heterofloral diagnosis.

Wednesday, January 05, 2011

Malaysian Honey Kills Breast, Cervical Cancer Cells

Tualang Honey Induces Apoptosis and Disrupts the Mitochondrial Membrane Potential of Human Breast and Cervical Cancer Cell Lines
Food and Chemical Toxicology, Article in Press

Honey is reported to contain various compounds such as phenols, vitamins and antioxidants.

The present study investigates the anticancer potential of Tualang honey (Agromas) (TH) in human breast (MCF-7 and MDA-MB-231) and cervical (HeLa) cancer cell lines; as well as in the normal breast epithelial cell line, MCF-10A.

The cells were treated with increasing doses of TH (1-10%) for up to 72 h. Increase in lactate dehydrogenase (LDH) leakage from the cell membranes indicates that TH is cytotoxic to all three cancer cells with effective concentrations (EC50) of 2.4 – 2.8%. TH is however, not cytotoxic to the MCF-10A cells.

Reactivity with annexin V fluorescence antibody and propidium iodide as analysed by flow cytometry and fluorescence microscopy shows that apoptosis occurred in these cancer cells. TH also reduced the mitochondrial membrane potential (Δψm) in the cancer cell lines after 24 h of treatment. The activation of caspase-3/7 and -9 was observed in all TH-treated cancer cells indicating the involvement of mitochondrial apoptotic pathway.

This study shows that TH has significant anticancer activity against human breast and cervical cancer cell lines.

Tuesday, January 04, 2011

Honey, Propolis Component Protects Liver

Chrysin Abrogates Early Hepatocarcinogenesis and Induces Apoptosis in N-Nitrosodiethylamine-Induced Preneoplastic Nodules in Rats
Toxicology and Applied Pharmacology, Article in Press

Flavonoids possess strong anti-oxidant and cancer chemopreventive activities.

Chrysin (5,7-dihydroxyflavone) occurs naturally in many plants, honey, and propolis. In vitro, chrysin acts as a general anti-oxidant, causes cell cycle arrest and promotes cell death. However, the mechanism by which chrysin inhibits cancer cell growth and the subcellular pathways activated remains poorly understood.

Effect of dietary supplementation with chrysin on proliferation and apoptosis during diethylnitrosamine (DEN)-induced early hepatocarcinogenesis was investigated in male Wistar rats.

To induce hepatocarcinogenesis, rats were given DEN injections (i.p, 200 mg/kg) three times at 15 day interval. An oral dose of chrysin (250 mg/kg bodyweight) was given three times weekly for 3 weeks, commencing 1 week after the last dose of DEN. Changes in the mRNA expression of COX-2, NFkB p65, p53, Bcl-xL and β-arrestin-2 were assessed by quantitative real-time PCR. Changes in the protein levels were measured by western blotting.

Chrysin administration significantly (P < 0.001) reduced the number and size of nodules formed. Also, a significant (P < 0.01) reduction in serum activities of AST, ALT, ALP, LDH and γGT were noticed. Expression of COX-2 and NFkB p65 were significantly reduced whereas that of p53, Bax and caspase3 increased at the mRNA and protein levels.

Likewise, a decrease in levels of β-arrestin and the anti-apoptotic marker Bcl-xL was also noted.

These findings suggest that chrysin exerts global hepato-protective effect and its chemopreventive activity is associated with p53-mediated apoptosis during early hepatocarcinogenesis.

Monday, January 03, 2011

Possible Mechanism for Royal Jelly’s Estrogen-Like Effects

Fatty Acids Derived from Royal Jelly Are Modulators of Estrogen Receptor Functions
PLoS ONE, 5(12), December 22, 2010

Royal jelly (RJ) excreted by honeybees and used as a nutritional and medicinal agent has estrogen-like effects, yet the compounds mediating these effects remain unidentified.

The possible effects of three RJ fatty acids (FAs) (10-hydroxy-2-decenoic-10H2DA, 3,10-dihydroxydecanoic-3,10DDA, sebacic acid-SA) on estrogen signaling was investigated in various cellular systems.

In MCF-7 cells, FAs, in absence of estradiol (E2), modulated the estrogen receptor (ER) recruitment to the pS2 promoter and pS2 mRNA levels via only ERβ but not ERα, while in presence of E2 FAs modulated both ERβ and ERα. Moreover, in presence of FAs, the E2-induced recruitment of the EAB1 co-activator peptide to ERα is masked and the E2-induced estrogen response element (ERE)-mediated transactivation is inhibited.

In HeLa cells, in absence of E2, FAs inhibited the ERE-mediated transactivation by ERβ but not ERα, while in presence of E2, FAs inhibited ERE-activity by both ERβ and ERα. Molecular modeling revealed favorable binding of FAs to ERα at the co-activator-binding site, while binding assays showed that FAs did not bind to the ligand-binding pocket of ERα or ERβ.

In KS483 osteoblasts, FAs, like E2, induced mineralization via an ER-dependent way.

Our data propose a possible molecular mechanism for the estrogenic activities of RJ's components which, although structurally entirely different from E2, mediate estrogen signaling, at least in part, by modulating the recruitment of ERα, ERβ and co-activators to target genes…

In this study, we determined the possible estrogenic/antiestrogenic properties of 10H2DA, 3,10DDA and SA, isolated from RJ and identified by spectroscopic methods [6]. In choosing the concentrations we considered 1) the commonly used RJ dietary supplementation (1–3 g daily), 2) the concentration of 10H2DA and the concentration of sebacic acid in RJ (3–6% and 0.5% respectively) [34], [35], 3) the concentration of 10H2DA, sebacic acid and 3,10 DDA as well as 10HDA acid in marketed RJ samples in Greece (40–50%, 5%, 4% and 20% respectively), 4) the human blood volume and bioavailability. Based on the above information, we decided to examine the biological effects of FAs in a concentration range of 10−10 M–10−5 M, which are physiologically achievable concentrations.

Sunday, January 02, 2011

Recent Patents on Topical Application of Honey in Wound and Burn Management

Recent Pat Inflamm Allergy Drug Discov, 2010 Dec 21

Topical application of honey to burn and wounds has been found to be effective in controlling infection and producing a clean granulating bed. It is suggested that the wound healing effect of honey may in part be related to the release of inflammatory cytokines from surrounding tissue cells, mainly monocytes and macrophages.

It has been reported that honey hastens wound healing by accelerating wound contractions. Microscopic evaluation demonstrated that there was a significant acceleration of dermal repair in wound treated with honey.

Macroscopic and microscopic observations under in vivo assessment suggested that the topical application of honey might have favourable influences on the various phases of burn and wound healing hence accelerating the healing process.

The regulatory effects of honey are related to components other than the sugars. However, the mechanisms by which honey affects the release of anti inflammatory agents and growth factors from monocytic cells are as yet unclear. Whether honey affects other cell types, particularly endothelial cells and fibroblasts, involved in wound healing also needs to be clarified.

The present article is a short review of recent patents on the healing effect of honey in wound and burn management.

Saturday, January 01, 2011

Honey, Propolis Component a Possible Anti-Cancer Agent

Chrysin-Induced Apoptosis is Mediated Through p38 and Bax Activation in B16-F1 and A375 Melanoma Cells
Int J Oncol, 2010 Dec 17
Chrysin (5,7-dihydroxyflavone) is a natural and biologically active compound extracted from honey, plants and propolis. It possesses anti-inflammatory activity, anti-oxidant properties and promotes cell death by perturbing cell cycle progression.

In this study, our attention focused on the possible role that chrysin may have as a potential anti-cancer agent, and we tested its biological activity in murine and human melanoma cell lines (B16-F1 and A375).

This study demonstrated that chrysin reduced melanoma cell proliferation and induced cell differentiation in both human and murine melanoma cells through synthesis increase and intracellular accumulation of protoporphirin IX (PpIX).

Furthermore, following treatments with chrysin an increase in the expression of porphobilinogen deaminase (PBG-D) was noted. This study demontrated also that chrysin induces cell death in human and murine melanoma cells through caspase-dependent mechanisms, involving down-regulation of ERK 1/2, and activation of p38 MAP kinases.

Induction of cell death may be a promising therapeutic approach in cancer therapy. Our results suggest that chrysin may be considered a potential candidate for both cancer prevention and treatment.